Drug Safety is a highly regarded peer-reviewed journal dedicated to all aspects of drug safety and adverse drug reactions. It provides comprehensive coverage of preclinical and clinical drug safety research, aiming to improve patient outcomes through enhanced pharmacovigilance.
The journal publishes original research articles, reviews, and case reports on topics such as adverse drug reactions, drug interactions, risk-benefit assessment, and post-market surveillance. It is indexed in leading databases, including MEDLINE, EMBASE, and Scopus, ensuring a broad readership among clinicians, researchers, and regulatory professionals.
Drug Safety is an essential resource for anyone involved in drug development, regulatory affairs, or clinical practice. Submit your manuscript to contribute to the advancement of drug safety knowledge and practices. Learn more about the journal scope and author guidelines on the publisher's website.